Interleukin signaling - PubMed

Interleukin signaling

Christian A J Vosshenrich et al. Curr Biol. 2002.

Free article

Similar articles

• Cutting edge: early IL-4 production governs the requirement for IL-27-WSX-1 signaling in the development of protective Th1 cytokine responses following Leishmania major infection.

  Artis D, Johnson LM, Joyce K, Saris C, Villarino A, Hunter CA, Scott P. Artis D, et al. J Immunol. 2004 Apr 15;172(8):4672-5. doi: 10.4049/jimmunol.172.8.4672. J Immunol. 2004. PMID: 15067040

• Alpha 4 integrin-induced cytokine production and eosinophil function.

  Broide DH. Broide DH. Springer Semin Immunopathol. 1995;16(4):405-15. doi: 10.1007/BF00196096. Springer Semin Immunopathol. 1995. PMID: 7570291 Review. No abstract available.

• IL-27 signaling compromises control of bacterial growth in mycobacteria-infected mice.

  Pearl JE, Khader SA, Solache A, Gilmartin L, Ghilardi N, deSauvage F, Cooper AM. Pearl JE, et al. J Immunol. 2004 Dec 15;173(12):7490-6. doi: 10.4049/jimmunol.173.12.7490. J Immunol. 2004. PMID: 15585875

• Interleukin-6. A multifunctional regulator of growth and differentiation.

  Lee F, Chiu CP, Wideman J, Hodgkin P, Hudak S, Troutt L, Ng T, Moulds C, Coffman R, Zlotnik A, et al. Lee F, et al. Ann N Y Acad Sci. 1989;557:215-28, discussion 228-9. Ann N Y Acad Sci. 1989. PMID: 2786696 No abstract available.

• Plasticity and cross-talk of interleukin 6-type cytokines.

  Garbers C, Hermanns HM, Schaper F, Müller-Newen G, Grötzinger J, Rose-John S, Scheller J. Garbers C, et al. Cytokine Growth Factor Rev. 2012 Jun;23(3):85-97. doi: 10.1016/j.cytogfr.2012.04.001. Epub 2012 May 15. Cytokine Growth Factor Rev. 2012. PMID: 22595692 Review.

Cited by

• Double-edged sword of JAK/STAT signaling pathway in viral infections: novel insights into virotherapy.

  Mahjoor M, Mahmoudvand G, Farokhi S, Shadab A, Kashfi M, Afkhami H. Mahjoor M, et al. Cell Commun Signal. 2023 Oct 2;21(1):272. doi: 10.1186/s12964-023-01240-y. Cell Commun Signal. 2023. PMID: 37784164 Free PMC article. Review.

• The Interleukin-1 (IL-1) Superfamily Cytokines and Their Single Nucleotide Polymorphisms (SNPs).

  Behzadi P, Sameer AS, Nissar S, Banday MZ, Gajdács M, García-Perdomo HA, Akhtar K, Pinheiro M, Magnusson P, Sarshar M, Ambrosi C. Behzadi P, et al. J Immunol Res. 2022 Mar 26;2022:2054431. doi: 10.1155/2022/2054431. eCollection 2022. J Immunol Res. 2022. PMID: 35378905 Free PMC article. Review.

• Kinase inhibitors in the treatment of immune-mediated disease.

  Kontzias A, Laurence A, Gadina M, O'Shea JJ. Kontzias A, et al. F1000 Med Rep. 2012;4:5. doi: 10.3410/M4-5. Epub 2012 Mar 1. F1000 Med Rep. 2012. PMID: 22403586 Free PMC article.

• The kinase inhibitor tofacitinib in patients with rheumatoid arthritis: latest findings and clinical potential.

  Cutolo M. Cutolo M. Ther Adv Musculoskelet Dis. 2013 Feb;5(1):3-11. doi: 10.1177/1759720X12470753. Ther Adv Musculoskelet Dis. 2013. PMID: 23515130 Free PMC article.

• Interleukins as Mediators of the Tumor Cell-Bone Cell Crosstalk during the Initiation of Breast Cancer Bone Metastasis.

  Haider MT, Ridlmaier N, Smit DJ, Taipaleenmäki H. Haider MT, et al. Int J Mol Sci. 2021 Mar 12;22(6):2898. doi: 10.3390/ijms22062898. Int J Mol Sci. 2021. PMID: 33809315 Free PMC article. Review.

MeSH terms

Substances